Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk.

Similar presentations


Presentation on theme: "Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk."— Presentation transcript:

1 Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia by Francesco Buccisano, Luca Maurillo, Alessandra Spagnoli, Maria Ilaria Del Principe, Daniela Fraboni, Paola Panetta, Tiziana Ottone, Maria Irno Consalvo, Serena Lavorgna, Pietro Bulian, Emanuele Ammatuna, Daniela F. Angelini, Adamo Diamantini, Selenia Campagna, Licia Ottaviani, Chiara Sarlo, Valter Gattei, Giovanni Del Poeta, William Arcese, Sergio Amadori, Francesco Lo Coco, and Adriano Venditti Blood Volume 116(13): September 30, 2010 ©2010 by American Society of Hematology

2 Clinical outcome in different cytogenetic groups according to MRD status after consolidation. Francesco Buccisano et al. Blood 2010;116: ©2010 by American Society of Hematology

3 Assessment of MRD at the end of consolidation splits FLT3 wild-type in 2 categories with different prognoses. Francesco Buccisano et al. Blood 2010;116: ©2010 by American Society of Hematology

4 AML risk stratification may be simplified integrating determination of MRD at the end of consolidation, with conventional cytogenetic/genetic classification. Francesco Buccisano et al. Blood 2010;116: ©2010 by American Society of Hematology


Download ppt "Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk."

Similar presentations


Ads by Google